Peer Review

The Dec. 9, 1996, issue of The Scientist discusses researcher disagreement with the National Institutes of Health plan to improve its peer-review processes [T.W. Durso, page 1]. My reading of the peer-review literature, supplemented by the conduct of hundreds of peer reviews, leads me to the following documented conclusions on the subject (R.N. Kostoff, "The Handbook of Research Impact Assessment," 6th ed., Summer 1996, Defense Technical Information Center Report No. ADA296021; R.N. Kostoff, "F

Written byRonald Kostoff
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Dec. 9, 1996, issue of The Scientist discusses researcher disagreement with the National Institutes of Health plan to improve its peer-review processes [T.W. Durso, page 1]. My reading of the peer-review literature, supplemented by the conduct of hundreds of peer reviews, leads me to the following documented conclusions on the subject (R.N. Kostoff, "The Handbook of Research Impact Assessment," 6th ed., Summer 1996, Defense Technical Information Center Report No. ADA296021; R.N. Kostoff, "Federal Research Impact Assessment: Axioms, Approaches, Applications," Scientometrics, 34:2, 1995). For evaluating basic research proposals, the three main criteria are research merit, research approach, and team quality. These map quite well into the three criteria proposed by the NIH Rating of Grant Applications committee (significance/approach/feasibility).

For research sponsored by a mission-oriented organization, a fourth factor related to mission relevance is useful. To ensure equity for evaluating truly fundamental research, a very liberal interpretation of mission relevance is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies